Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-048366
Filing Date
2013-08-29
Accepted
2013-08-29 10:38:55
Documents
4
Period of Report
2013-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v353850_6k.htm 6-K 1369463
2 GRAPHIC image_001.gif GRAPHIC 1802
3 GRAPHIC image_001.jpg GRAPHIC 2701
4 GRAPHIC image_003.jpg GRAPHIC 2295
  Complete submission text file 0001144204-13-048366.txt   1380270
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 131067675
SIC: 2834 Pharmaceutical Preparations